✦ LIBER ✦

Measurement of the Soluble Membrane Receptors for Tumor Necrosis Factor and Lymphotoxin in the Sera of Patients with Gynecologic Malignancy

✍ Scribed by Elizabeth A. Grosen; Gale A. Granger; Maki Gatanaga; Elizabeth K. Ininns; Chenduen Hwang; Philip Disaia; Michael Berman; Alberto Manetta; Dennis Emma; Tetsuya Gatanaga

Book ID: 115615882
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 544 KB
Volume: 50
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1993.1166

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurement of the soluble membrane rece

Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy

✍ E.A. Grosen; G.A. Granger; M. Gatanaga; E.K. Ininns; C. Hwang; P. DiSaia; M. Ber 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Blocking factors (BF) and soluble recept

Blocking factors (BF) and soluble receptors for tumor necrosis factor (TNF) and lymphotoxin (LT) in the cell-free ascites and tumor culture supernatants of patients with gynecologic malignancies

✍ Elizabeth Grosen; Michael Berman; Philip DiSaia; Alberto Manetta; Gale Granger 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Increased levels of soluble tumor necros

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

✍ Andrew P. Cope; Deena Gibbons; Fionula M. Brennan; Marc Feldmann; Dan Aderka; Mi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 815 KB

The elevation of plasma soluble tumor ne

The elevation of plasma soluble tumor necrosis factor receptor levels by TNF induction therapy for patients with malignancy

✍ Yasuhito Abe; Katsuhiko Kimura; Atsushi Horiuchi; Yuji Watanabe; Shigeru Kimura 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 551 KB

Association between serum levels of solu

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study

✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics

Serum levels of soluble tumor-necrosis-f

Serum levels of soluble tumor-necrosis-factor receptors in patients with benign and malignant HPV-associated anogenital lesions

✍ Magdalena Malejczyk; Jaroslaw Jóźwiak; Anna Osiecka; Piotr I. Roszkowski; Walent 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB 👁 2 views

The levels of type-I and type-II soluble TNF-␣ receptors (sTNF-Rs) were evaluated in sera from patients with various human-papillomavirus-(HPV)-associated benign and malignant anogenital lesions using specific enzyme-linked immunobiological assays. In patients with benign HPV6/11-associated condylom